Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

High content cellular microarray for automated drug target deconvolution

Despite the promising paradigm offered by high-content screening, the concrete execution of hundred of thousands of visual cell-based experiments has remained highly challenging in terms of both statistical robustness and speed. An efficient computational method for cellular microarrays was developed at Institut Pasteur-Korea that allow for high speed, high content genome-wide siRNA screening. Details of the method and examples of data from genome-wide analyses will be featured in this presentation. In particular, we will demonstrate that the sudden ability to dramatically increase the number of experiments has created the opportunity for automated identification of a drug’s target.

Author information

Correspondence to Yong-Jun Kwon.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Kwon, Y., Kim, H.C., Kim, N.Y. et al. High content cellular microarray for automated drug target deconvolution. BMC Proc 5, P76 (2011). https://doi.org/10.1186/1753-6561-5-S1-P76

Download citation

Keywords

  • Public Health
  • Drug Target
  • Automate Identification
  • Statistical Robustness
  • Efficient Computational Method